CARDURION PHARMACEUTICALS
Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takeda’s strategy to leverage external innovation by... placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion. In April 2018, Cardurion announced the Company entered an exclusive licensing agreement with Astellas to develop and commercialize CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. With recent evidence supporting that inhibition of PDE-9 has potential to restore heart-protective mechanisms that are dysfunctional in heart failure, CRD-733 has the potential to address the cell-signaling breakdown that contributes to the progression of heart failure.
CARDURION PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.cardurion.com
Total Employee:
11+
Status:
Active
Contact:
617-996-1433
Email Addresses:
[email protected]
Total Funding:
325.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Panacea Biotec
Panacea Biotec is an Innovation driven Biotechnology company.
Current Employees Featured
Founder
Investors List
Polaris Partners
Polaris Partners investment in Series B - Cardurion Pharmaceuticals
Bain Capital
Bain Capital investment in Series B - Cardurion Pharmaceuticals
Takeda
Takeda investment in Series B - Cardurion Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series A - Cardurion Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.cardurion.com Semrush global rank: 5.55 M Semrush visits lastest month: 1.53 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
